Top compounds associated with response to POLD1


Feature Type Standardized
Nominal ANOVA
mRNA clofarabine CTRPv2 pan-cancer AAC 0.24 1e-11
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.2 3e-09
mRNA barasertib CTRPv2 pan-cancer AAC 0.22 5e-09
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.2 9e-09
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.24 9e-09
mRNA STF-31 CTRPv2 pan-cancer AAC 0.24 1e-08
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-08
mRNA decitabine CTRPv2 pan-cancer AAC 0.19 1e-08
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.23 2e-08
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 2e-08
Download CSV